Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Topical Ruxolitinib may safely treat severe hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Apremilast did not work for treating severe alopecia areata.

Ruxolitinib helped a man regrow his beard after years of hair loss.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.